Patient and disease–specific induced pluripotent stem cells for discovery of personalized cardiovascular drugs and therapeutics

DT Paik, M Chandy, JC Wu, EH Ohlstein - Pharmacological reviews, 2020 - Elsevier
Human induced pluripotent stem cells (iPSCs) have emerged as an effective platform for
regenerative therapy, disease modeling, and drug discovery. iPSCs allow for the production …

CRISPR modeling and correction of cardiovascular disease

N Liu, EN Olson - Circulation research, 2022 - Am Heart Assoc
Cardiovascular disease remains the leading cause of morbidity and mortality in the
developed world. In recent decades, extraordinary effort has been devoted to defining the …

Drug screening in human PSC-cardiac organoids identifies pro-proliferative compounds acting via the mevalonate pathway

RJ Mills, BL Parker, GA Quaife-Ryan, HK Voges… - Cell stem cell, 2019 - cell.com
We have previously developed a high-throughput bioengineered human cardiac organoid
(hCO) platform, which provides functional contractile tissue with biological properties similar …

High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells

A Sharma, PW Burridge, WL McKeithan… - Science translational …, 2017 - science.org
Tyrosine kinase inhibitors (TKIs), despite their efficacy as anticancer therapeutics, are
associated with cardiovascular side effects ranging from induced arrhythmias to heart …

Induced pluripotent stem cells for cardiovascular disease modeling and precision medicine: a scientific statement from the American Heart Association

K Musunuru, F Sheikh, RM Gupta… - Circulation: Genomic …, 2018 - Am Heart Assoc
Induced pluripotent stem cells (iPSCs) offer an unprece-dented opportunity to study human
physiology and disease at the cellular level. They also have the potential to be leveraged in …

Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering

MF Tenreiro, AF Louro, PM Alves… - NPJ Regenerative …, 2021 - nature.com
The adult heart is a vital and highly specialized organ of the human body, with limited
capability of self-repair and regeneration in case of injury or disease. Engineering …

PRDM16 is a compact myocardium-enriched transcription factor required to maintain compact myocardial cardiomyocyte identity in left ventricle

T Wu, Z Liang, Z Zhang, C Liu, L Zhang, Y Gu… - Circulation, 2022 - Am Heart Assoc
Background: Left ventricular noncompaction cardiomyopathy (LVNC) was discovered half a
century ago as a cardiomyopathy with excessive trabeculation and a thin ventricular wall. In …

Modeling cardiovascular risks of e-cigarettes with human-induced pluripotent stem cell–derived endothelial cells

WH Lee, SG Ong, Y Zhou, L Tian, HR Bae… - Journal of the American …, 2019 - jacc.org
Background: Electronic cigarettes (e-cigarettes) have experienced a tremendous increase in
use. Unlike cigarette smoking, the effects of e-cigarettes and their constituents on mediating …

Activation of PDGF pathway links LMNA mutation to dilated cardiomyopathy

J Lee, V Termglinchan, S Diecke, I Itzhaki, CK Lam… - Nature, 2019 - nature.com
Abstract Lamin A/C (LMNA) is one of the most frequently mutated genes associated with
dilated cardiomyopathy (DCM). DCM related to mutations in LMNA is a common inherited …

Use of human induced pluripotent stem cell–derived cardiomyocytes to assess drug cardiotoxicity

A Sharma, WL McKeithan, R Serrano, T Kitani… - Nature protocols, 2018 - nature.com
Cardiotoxicity has historically been a major cause of drug removal from the pharmaceutical
market. Several chemotherapeutic compounds have been noted for their propensities to …